ASBP
Aspire Biopharma Holdings, Inc.Company with tickers: ASBP, ASBPW
CIK
1847345
CUSIP
738920206
Shares Outstanding
1,295,234
13F Activity (30d)
12 filings
12 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $28,353 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Cost of Revenue | — | ||||
| Gross Profit | $5,750 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Operating Expenses | $1,651,919 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Research & Development | $296,723 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Operating Income | $-1,646,169 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Net Income | $-3,222,892 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Basic) | $-20.57 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Diluted) | $-20.57 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |